Editor's Note: From the Cyclooxygenase-2 Inhibitor Celecoxib to a Novel Class of 3-Phosphoinositide-Dependent Protein Kinase-1 Inhibitors

Cancer Res. 2019 Apr 1;79(7):1716. doi: 10.1158/0008-5472.CAN-19-0502.
No abstract available

Publication types

  • Published Erratum